Heart failure (HF) units have been established to systematize the diagnosis, treatment, and clinical follow-up of patients with HF, incorporating multidisciplinary teams, standardized protocols, and structured follow-up. In developed countries, their main benefit is the reduction of hospitalizations and the optimization of guideline-based treatment. (1) In Latin America, where health care systems exhibit greater heterogeneity and structural restrictions, their implementation remains limited.
In the research study published by the Argentine Journal of Cardiology, “Impact of a Specialized Heart Failure Unit on Patients Hospitalized for Acute Heart Failure: Analysis of a Decade of Experience,” 3368 hospitalizations for acute HF over a ten-year period were analyzed at a high-complexity center in Argentina, comparing an initial phase (2014–2019) with a consolidation phase (2020–2024) of the program. The most significant finding was a sustained reduction in the length of hospital stay, from 9.3 to 2.8 days, without an increase in in-hospital mortality or 30-day rehospitalization. (2) This result is clinically significant, as prolonged hospital stays for acute HF are associated with higher costs, complications, and a poorer prognosis. (3)
Although this study provides local evidence and suggests a consistent positive impact of HF units, it should be noted that the model was developed at a high-complexity, referral center. Its implementation required a considerable set of resources, such as staff specialized in HF, access to a day hospital, and telemonitoring, among others. Unfortunately, this level of resources is not typically available in most public centers or in a significant number of private centers in the region. This reality is evident in the ARGEN-IC registry, (4) a multicenter study with heterogeneous complexity, which reported longer hospital stays and reduced access to early outpatient follow-up, illustrating the gap between what has been demonstrated and what is replicable.
However, it is likely that not all components of the program have an equal impact on the observed outcomes; therefore, the real challenge for the future appears to be identifying which components are indispensable and which could be adapted for centers with fewer resources. An interesting contribution of this study was the use of the coefficient of variation (CV) as an indicator of care stability. In this regard, this methodological tool could also be applied to evaluate adapted versions of the model and thus generate local evidence to guide its gradual implementation in our setting. (5)
The study’s findings encourage reconsidering the design of HF units in versions adapted to available resources, identifying those components of greater clinical impact, with the goal of expanding access to a population with increasing prevalence, as patients with HF.
Ethical considerations
Not applicable.
